$SRDX
SURMODICS INC Stock $srdx

$srdx Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-K Financial Statement

#000156459018030336 Filed on November 30, 2018

Income Statement

Concept	2018 Q3	2018 Q2	2018 Q1
Revenue	$23.04M	$22.23M	$19.06M
YoY Change	14.86%	24.94%	8.88%
Cost Of Revenue	$4.090M	$4.104M	$2.910M
YoY Change	23.19%	40.84%	13.67%
Gross Profit	$18.95M	$18.12M	$16.15M
YoY Change	13.2%	21.83%	8.1%
Gross Profit Margin	82.26%	81.54%	84.74%
Selling, General & Admin	$6.510M	$5.980M	$6.440M
YoY Change	22.6%	14.3%	26.77%
% of Gross Profit	34.35%	33.0%	39.88%
Research & Development	$12.59M	$9.778M	$10.77M
YoY Change	29.66%	23.35%	31.18%
% of Gross Profit	66.44%	53.95%	66.69%
Depreciation & Amortization	$1.720M	$1.605M	$1.586M
YoY Change	10.97%	14.23%	19.43%
% of Gross Profit	9.08%	8.86%	9.82%
Operating Expenses	$21.39M	$9.778M	$6.440M
YoY Change	31.07%	-25.69%	-51.47%
Operating Profit	-$2.441M	-$6.250M	$525.0K
YoY Change	-688.19%	-458.58%	-68.69%
Interest Expense	$410.0K	$960.0K	-$210.0K
YoY Change	-286.36%	-295.92%	75.0%
% of Operating Profit			-40.0%
Other Income/Expense, Net	$0.00	$955.0K	-$211.0K
YoY Change		-294.9%
Pretax Income	-$2.030M	-$5.295M	$314.0K
YoY Change	-1168.42%	-522.59%	-79.87%
Income Tax	-$680.0K	-$2.613M	-$1.220M
% Of Pretax Income			-388.54%
Net Earnings	-$1.753M	-$2.682M	$1.534M
YoY Change	-538.25%	-472.5%	203.16%
Net Earnings / Revenue	-7.61%	-12.07%	8.05%
Basic Earnings Per Share	-$0.13	-$0.20	$0.12
Diluted Earnings Per Share	-$0.13	-$0.20	$0.11
COMMON SHARES
Basic Shares Outstanding		13.20M	13.10M
Diluted Shares Outstanding		13.20M	13.47M

Balance Sheet

Concept	2018 Q3	2018 Q2	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$64.70M	$62.00M	$66.00M
YoY Change	33.95%	41.88%	42.55%
Cash & Equivalents	$23.32M	$27.62M	$28.06M
Short-Term Investments	$41.40M	$34.80M	$38.30M
Other Short-Term Assets	$2.900M	$3.500M	$2.700M
YoY Change	141.67%	40.0%	80.0%
Inventory	$4.016M	$4.000M	$4.000M
Prepaid Expenses
Receivables	$8.877M	$8.300M	$7.200M
Other Receivables	$1.100M	$1.100M	$1.400M
Total Short-Term Assets	$81.53M	$78.80M	$81.30M
YoY Change	33.91%	36.64%	39.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.14M	$27.98M	$25.80M
YoY Change	31.39%	25.73%	25.24%
Goodwill	$27.03M
YoY Change	-0.92%
Intangibles	$17.68M
YoY Change	-14.0%
Long-Term Investments			$4.000M
YoY Change
Other Assets	$1.446M	$7.600M	$4.500M
YoY Change	61.2%	766.59%	-13.46%
Total Long-Term Assets	$82.61M	$81.20M	$82.00M
YoY Change	9.11%	9.4%	12.48%
TOTAL ASSETS
Total Short-Term Assets	$81.53M	$78.80M	$81.30M
Total Long-Term Assets	$82.61M	$81.20M	$82.00M
Total Assets	$164.1M	$160.0M	$163.3M
YoY Change	20.16%	21.31%	24.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.546M	$1.700M	$2.000M
YoY Change	6.26%	-11.27%	-4.76%
Accrued Expenses	$11.90M	$7.900M	$7.900M
YoY Change	112.5%	79.55%	119.44%
Deferred Revenue	$9.646M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$35.13M	$31.60M	$34.20M
YoY Change	258.39%	321.33%	410.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.720M	$19.70M	$15.70M
YoY Change	195.15%	31.33%	3.97%
Total Long-Term Liabilities	$5.720M	$19.70M	$15.70M
YoY Change	195.15%	31.33%	3.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.13M	$31.60M	$34.20M
Total Long-Term Liabilities	$5.720M	$19.70M	$15.70M
Total Liabilities	$55.53M	$51.20M	$50.00M
YoY Change	121.78%	127.56%	128.31%
SHAREHOLDERS EQUITY
Retained Earnings	$97.62M
YoY Change	-4.37%
Common Stock	$8.277M
YoY Change	36.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$108.6M	$108.7M	$113.4M
YoY Change
Total Liabilities & Shareholders Equity	$164.1M	$160.0M	$163.3M
YoY Change	20.16%	21.3%	24.37%

Cashflow Statement

Concept	2018 Q3	2018 Q2	2018 Q1
OPERATING ACTIVITIES
Net Income	-$1.753M	-$2.682M	$1.534M
YoY Change	-538.25%	-472.5%	203.16%
Depreciation, Depletion And Amortization	$1.720M	$1.605M	$1.586M
YoY Change	10.97%	14.23%	19.43%
Cash From Operating Activities	$4.830M	$1.790M	$26.82M
YoY Change	-24.41%	-47.35%	1061.04%
INVESTING ACTIVITIES
Capital Expenditures	-$2.670M	-$7.400M	-$2.720M
YoY Change	72.26%	268.16%	106.06%
Acquisitions
YoY Change
Other Investing Activities	-$6.590M	$7.520M	-$17.38M
YoY Change	-1198.33%	187.02%	131.42%
Cash From Investing Activities	-$9.270M	$130.0K	-$20.10M
YoY Change	886.17%	-78.33%	127.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	500.0K	-2.210M	-700.0K
YoY Change	-208.7%	-44.89%	-736.36%
NET CHANGE
Cash From Operating Activities	4.830M	1.790M	26.82M
Cash From Investing Activities	-9.270M	130.0K	-20.10M
Cash From Financing Activities	500.0K	-2.210M	-700.0K
Net Change In Cash	-3.940M	-290.0K	6.020M
YoY Change	-178.96%	2800.0%	-193.92%
FREE CASH FLOW
Cash From Operating Activities	$4.830M	$1.790M	$26.82M
Capital Expenditures	-$2.670M	-$7.400M	-$2.720M
Free Cash Flow	$7.500M	$9.190M	$29.54M
YoY Change	-5.54%	69.87%	713.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2017	srdx	Contingent Consideration Expense Gain ContingentConsiderationExpenseGain	-127000
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	31802000
CY2018Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	41352000
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8877000
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7211000
CY2018Q3	us-gaap	Inventory Net InventoryNet	4016000
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13398036
CY2018Q1	dei	Entity Public Float EntityPublicFloat	255000000
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23318000
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16534000
CY2018Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	350000
CY2017Q3	us-gaap	Inventory Net InventoryNet	3516000
CY2018Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1152000
CY2017Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	599000
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2462000
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1221000
CY2018Q3	us-gaap	Assets Current AssetsCurrent	81527000
CY2017Q3	us-gaap	Assets Current AssetsCurrent	60883000
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30143000
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22942000
CY2018Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	6304000
CY2017Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4027000
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17683000
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20562000
CY2018Q3	us-gaap	Goodwill Goodwill	27032000
CY2017Q3	us-gaap	Goodwill Goodwill	27282000
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1446000
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	897000
CY2018Q3	us-gaap	Assets Assets	164135000
CY2017Q3	us-gaap	Assets Assets	136593000
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2546000
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2396000
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5635000
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3822000
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6265000
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1773000
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	11041000
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1750000
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	35133000
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	9803000
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3425000
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	13114000
CY2018Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	11247000
CY2017Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	181000
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5720000
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1938000
CY2018Q3	us-gaap	Liabilities Liabilities	55525000
CY2017Q3	us-gaap	Liabilities Liabilities	25036000
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	670000
CY2018	srdx	Research Development And Other Revenue ResearchDevelopmentAndOtherRevenue	7959000
CY2017	us-gaap	Revenues Revenues	73112000
CY2017	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:ProductMember
CY2016	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:ProductMember
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10908000
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18000000
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20478000
CY2018	srdx	Acquisition Related Intangible Asset Amortization AcquisitionRelatedIntangibleAssetAmortization	2491000
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	66009000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-8799000
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	90135000
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13997000
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11422000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40973000
CY2018	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:ProductMember
CY2016	srdx	Acquisition Related Intangible Asset Amortization AcquisitionRelatedIntangibleAssetAmortization	2422000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31817000
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18498000
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24111000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	7103000
CY2018	us-gaap	Revenues Revenues	81336000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	16859000
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	851000
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	54507000
CY2016	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	3187000
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-504000
CY2016	us-gaap	Investment Income Net InvestmentIncomeNet	63000
CY2017	us-gaap	Investment Income Net InvestmentIncomeNet	390000
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	655000
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7607000
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	622000
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	3268000
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1677000
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1743000
CY2017	srdx	Acquisition Related Intangible Asset Amortization AcquisitionRelatedIntangibleAssetAmortization	2419000
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9646000
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	62000
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	437850
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	94415
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	827325
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	229039
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6819
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	47640
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1001905
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	269961
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	450495
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	110825
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	236302
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.10
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.63
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	15.68
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	31.52
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.30
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	24.08
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	13.89
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	30.65
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.54
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	34.08
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.46
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	30.18
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.28
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.91
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.63
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.95
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0218
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0174
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0189
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y9M18D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y7M6D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y7M6D
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.33
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.37
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	34400000
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	12400000
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M24D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M18D
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	12100000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	5100000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	241582
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	330000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-607000
CY2017Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	14900000
CY2018Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
CY2017Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	221000
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	710546
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.33
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1308000
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1798000
CY2018Q3	srdx	Deferred Tax Assets Impaired Investment DeferredTaxAssetsImpairedInvestment	1687000
CY2017Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3627000
CY2018Q3	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1896000
CY2018Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	538000
CY2018Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4541000
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	102072000
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	108610000
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	111557000
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	164135000
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	136593000
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	147000
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	230000
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.05
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.05
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	450000
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	450000
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1546000
CY2016	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1953000
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3844000
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	106833000
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	348000
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	96000
CY2017	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	4702000
CY2017	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	560000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3472000
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	340000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1749000
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4687000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4807000
CY2018	us-gaap	Profit Loss ProfitLoss	-4457000
CY2017	us-gaap	Profit Loss ProfitLoss	3926000
CY2016	us-gaap	Profit Loss ProfitLoss	9985000
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6431000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5555000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4873000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	4807000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	3472000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	3844000
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	675000
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-127000
CY2016	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1492000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	148000
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-474000
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-444000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2277000
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1000000
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	261000
CY2018	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	177000
CY2017	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	43000
CY2016	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	514000
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	85000
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	208000
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	427000
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-6000
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5413000
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2718000
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	66000
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-45000
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-13000
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3417000
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	97615000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1773000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	528000
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-911000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	513000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-97000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	143000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1584000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	599000
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13397647
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13094988
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13397647
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13094988
CY2017	srdx	Research Development And Other Revenue ResearchDevelopmentAndOtherRevenue	8535000
CY2016	srdx	Research Development And Other Revenue ResearchDevelopmentAndOtherRevenue	7164000
CY2016	us-gaap	Revenues Revenues	71366000
CY2018	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	7888000
CY2018	srdx	Contingent Consideration Expense Gain ContingentConsiderationExpenseGain	675000
CY2016	srdx	Contingent Consideration Expense Gain ContingentConsiderationExpenseGain	1492000
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-481000
CY2018	srdx	Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense	177000
CY2017	srdx	Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense	44000
CY2016	srdx	Gain Loss On Sale Of Strategic Investment And Other Nonoperating Income Expense GainLossOnSaleOfStrategicInvestmentAndOtherNonoperatingIncomeExpense	507000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3075000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-4457000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	3926000
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13157000
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13153000
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12998000
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13157000
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13389000
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13219000
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-38000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	49000
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-68000
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-661000
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2095000
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	71951000
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	63871000
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1336000
CY2016	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2498000
CY2018	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	5000000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-699000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2144000
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25859000
CY2018	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	177000
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1268000
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5156000
CY2017	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	43000
CY2016	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	513000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6070000
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11253000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23500000
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	91873000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16189000
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	270000
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-409000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55468000
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2089000
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5241000
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	368000
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	31140000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13457000
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	444000
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	494000
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3710000
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-842000
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-59000
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	76000
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	20651000
CY2017Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	31400000
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-124000
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-129000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34052000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14053000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25166000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9092000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6432000
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8192000
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	89000
CY2018	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	81536000
CY2017	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	73671000
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	24517000
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4702000
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4557000
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2156000
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	388000
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	96000
CY2018	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	925000
CY2016	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	305000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3393000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6510000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-199000
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-25000
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	193000
CY2016	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-100000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7134000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8453000
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30601000
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16534000
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24987000
CY2015Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	55588000
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23668000
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	914000
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2114000
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6710000
CY2018	srdx	Non Cash Transaction Acquisition Of Property Plant And Equipment Net Of Refundable Credits In Other Current Assets And Liabilities NonCashTransactionAcquisitionOfPropertyPlantAndEquipmentNetOfRefundableCreditsInOtherCurrentAssetsAndLiabilities	632000
CY2017	srdx	Non Cash Transaction Acquisition Of Property Plant And Equipment Net Of Refundable Credits In Other Current Assets And Liabilities NonCashTransactionAcquisitionOfPropertyPlantAndEquipmentNetOfRefundableCreditsInOtherCurrentAssetsAndLiabilities	109000
CY2016	srdx	Non Cash Transaction Acquisition Of Property Plant And Equipment Net Of Refundable Credits In Other Current Assets And Liabilities NonCashTransactionAcquisitionOfPropertyPlantAndEquipmentNetOfRefundableCreditsInOtherCurrentAssetsAndLiabilities	50000
CY2018	srdx	Noncash Transaction Acquisition Of Property Plant And Equipment In Long Term Deferred Rent NoncashTransactionAcquisitionOfPropertyPlantAndEquipmentInLongTermDeferredRent	1200000
CY2018	srdx	Non Cash Transaction Acquisition Of In Process Research And Development In Other Long Term Liabilities NonCashTransactionAcquisitionOfInProcessResearchAndDevelopmentInOtherLongTermLiabilities	2888000
CY2018	srdx	Noncash Transaction Accrual Of Employee Taxes On Common Stock Exercises NoncashTransactionAccrualOfEmployeeTaxesOnCommonStockExercises	130000
CY2016	srdx	Noncash Transaction Accrual Of Employee Taxes On Common Stock Exercises NoncashTransactionAccrualOfEmployeeTaxesOnCommonStockExercises	1585000
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10838000
CY2018Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	121000
CY2017Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	18000
CY2018Q3	srdx	Other Accrued Liabilities Other Current OtherAccruedLiabilitiesOtherCurrent	262000
CY2017Q3	srdx	Other Accrued Liabilities Other Current OtherAccruedLiabilitiesOtherCurrent	247000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2690000
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	12584000
CY2018	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	100000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2514000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2375000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2336000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1737000
CY2018	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0
CY2017	srdx	Impairment Losses Of Intangible Assets Indefinite Lived Excluding Goodwill Other ImpairmentLossesOfIntangibleAssetsIndefiniteLivedExcludingGoodwillOther	0
CY2018	srdx	Impairment Losses Of Intangible Assets Indefinite Lived Excluding Goodwill Other ImpairmentLossesOfIntangibleAssetsIndefiniteLivedExcludingGoodwillOther	0
CY2018Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2017	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	100000
CY2018	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	Product sales.<font style="font-style:normal;"> Product sales to third parties consist of OEM and distributor sales and are recognized at the time of shipment. The Company’s sales terms provide no right of return outside of the standard warranty policy. Payment terms are generally set at 30-45 days.</font>
CY2016	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	100000
CY2018	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Calibri;font-size:10pt;text-transform:none;font-variant: normal;">Deferred Revenue</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts received prior to satisfying the above revenue recognition criteria are recorded as deferred revenue in the accompanying consolidated balance sheets, with deferred revenue to be recognized beyond one year being classified as non-current deferred revenue. The Company had deferred revenue of $20.9 million and $0.3 million as of September 30, 2018 and 2017, respectively recorded in current and long-term deferred revenue on the consolidated balance sheets.</p>
CY2018	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4457000
CY2017	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3926000
CY2016	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	9985000
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.27%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Calibri;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Ultimate results could differ from those estimates.</p>
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2016	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	236000
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000
CY2018Q3	srdx	Goodwill Subject To Revaluation Due To Fluctuations In Exchange Rates GoodwillSubjectToRevaluationDueToFluctuationsInExchangeRates	13400000
CY2018Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	14500000
CY2016Q3	us-gaap	Goodwill Goodwill	26555000
CY2017	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	727000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2700000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2600000
CY2018	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	0
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	0
CY2016	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities	0
CY2018Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	41403000
CY2018Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	51000
CY2018Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	41352000
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	31817000
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	15000
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	31802000
CY2018Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	0
CY2017Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	0
CY2018	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0
CY2016	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0
CY2018Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1890000
CY2017Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1603000
CY2018Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	780000
CY2017Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	659000
CY2018Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1346000
CY2017Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1254000
CY2018	us-gaap	Depreciation Depreciation	3700000
CY2017	us-gaap	Depreciation Depreciation	3000000
CY2016	us-gaap	Depreciation Depreciation	2300000
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33512000
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	29927000
CY2017Q3	srdx	Accrued Clinical Study Expense Current AccruedClinicalStudyExpenseCurrent	411000
CY2018Q3	srdx	Accrued Purchases Current AccruedPurchasesCurrent	533000
CY2017Q3	srdx	Accrued Purchases Current AccruedPurchasesCurrent	596000
CY2018Q3	srdx	Customer Claim Current CustomerClaimCurrent	1000000
CY2018Q3	us-gaap	Construction Payable Current ConstructionPayableCurrent	1199000
CY2018	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-250000
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	311000
CY2017Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	501000
CY2018Q3	srdx	Accrued Clinical Study Expense Current AccruedClinicalStudyExpenseCurrent	2839000
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2017	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2017	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	196190
CY2017	srdx	Stock Repurchased During Period Average Price StockRepurchasedDuringPeriodAveragePrice	23.97
CY2018Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	25300000
CY2018	srdx	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	4807000
CY2017	srdx	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	3472000
CY2016	srdx	Allocated Share Based Compensation Expense Benefit AllocatedShareBasedCompensationExpenseBenefit	3844000
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5700000
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2018Q3	srdx	Performance Share Awards Fully Expensed PerformanceShareAwardsFullyExpensed	600000
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1118008
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-890000
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2125000
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6550000
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	51000
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-72000
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	250000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	41000
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	54000
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-98000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-798000
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2107000
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6702000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2006000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1085000
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	169000
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-271000
CY2016	srdx	Income Tax Reconciliation Contingent Consideration Gain Expense IncomeTaxReconciliationContingentConsiderationGainExpense	522000
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-85000
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-43000
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	135000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.245
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
	srdx	Tax Cuts And Jobs Act Change In Tax Rate Deferred Tax Asset Income Tax Expense TaxCutsAndJobsActChangeInTaxRateDeferredTaxAssetIncomeTaxExpense	1600000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1845000
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2461000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	5932000
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-724000
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-13000
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	142000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2063000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	960000
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	665000
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2500000
CY2018	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	158000
CY2017	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-52000
CY2016	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	258000
CY2017	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	313000
CY2016	us-gaap	Income Tax Reconciliation Deductions Qualified Production Activities IncomeTaxReconciliationDeductionsQualifiedProductionActivities	280000
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1710000
CY2017	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	706000
CY2016	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	571000
CY2016	srdx	Income Tax Reconciliation Gain On Strategic Investment And Corporate Subsidiary IncomeTaxReconciliationGainOnStrategicInvestmentAndCorporateSubsidiary	2630000
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	371000
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	948000
CY2016	srdx	Income Tax Reconciliation Acquisition Related Transaction Costs IncomeTaxReconciliationAcquisitionRelatedTransactionCosts	768000
CY2018	srdx	Income Tax Reconciliation Contingent Consideration Gain Expense IncomeTaxReconciliationContingentConsiderationGainExpense	165000
CY2017	srdx	Income Tax Reconciliation Contingent Consideration Gain Expense IncomeTaxReconciliationContingentConsiderationGainExpense	-45000
CY2018	srdx	Income Tax Reconciliation Unrealized Foreign Currency Exchange Loss Gain On Contingent Consideration Obligation IncomeTaxReconciliationUnrealizedForeignCurrencyExchangeLossGainOnContingentConsiderationObligation	-23000
CY2017	srdx	Income Tax Reconciliation Unrealized Foreign Currency Exchange Loss Gain On Contingent Consideration Obligation IncomeTaxReconciliationUnrealizedForeignCurrencyExchangeLossGainOnContingentConsiderationObligation	170000
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1582000
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	54000
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-338000
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	47000
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2000000
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-200000
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	600000
CY2018Q3	srdx	Deferred Tax Assets Liabilities Property Plant And Equipment DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment	-1019000
CY2017Q3	srdx	Deferred Tax Assets Liabilities Property Plant And Equipment DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment	-3335000
CY2017Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1123000
CY2017Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3370000
CY2017Q3	srdx	Deferred Tax Assets Impaired Investment DeferredTaxAssetsImpairedInvestment	2701000
CY2018Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4637000
CY2017Q3	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	242000
CY2017Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	810000
CY2017Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4511000
CY2018	srdx	Operating Loss Carryforwards Remaining Period OperatingLossCarryforwardsRemainingPeriod	P9Y
CY2017Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1481000
CY2016Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1508000
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1248000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	61000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	8000
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	77000
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	35000
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	21000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	735000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	216000
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	365000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	613000
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	105000
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	216000
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	161000
CY2018Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1559000
CY2018Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1400000
CY2017Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1200000
CY2016Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1200000
CY2018Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	400000
CY2017Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	500000
CY2016Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	600000
CY2018Q3	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0
CY2017Q3	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	700000
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	700000
CY2016	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000
CY2018	srdx	Additional Shares Of Common Stock To Stockholders AdditionalSharesOfCommonStockToStockholders	480059
CY2018	srdx	License Agreement Commencement Date LicenseAgreementCommencementDate	2006-03
CY2018Q3	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1.1602
CY2018Q3	srdx	Annual License Maintenance Fee Payable AnnualLicenseMaintenanceFeePayable	2100000
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	500000
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	100000
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	100000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	443000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	452000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	396000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	391000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	399000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1933000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4014000
CY2018	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2018	srdx	Number Of Sources Of Revenues NumberOfSourcesOfRevenues	2
CY2017Q4	us-gaap	Revenues Revenues	17013000
CY2018Q1	us-gaap	Revenues Revenues	19058000
CY2018Q2	us-gaap	Revenues Revenues	22227000
CY2018Q3	us-gaap	Revenues Revenues	23038000
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-633000
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	525000
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6250000
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2441000
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-1556000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	1534000
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-2682000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-1753000
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2016Q4	us-gaap	Revenues Revenues	17761000
CY2017Q1	us-gaap	Revenues Revenues	17503000
CY2017Q2	us-gaap	Revenues Revenues	17790000
CY2017Q3	us-gaap	Revenues Revenues	20058000
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	415000
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	2300000
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	506000
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	720000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	400000
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2017Q4	srdx	Tax Cuts And Jobs Act Change In Tax Rate Deferred Tax Asset Income Tax Expense TaxCutsAndJobsActChangeInTaxRateDeferredTaxAssetIncomeTaxExpense	1200000

Files In Submission

Name	View Source	Status
0001564590-18-030336-index-headers.html	Edgar Link	pending
0001564590-18-030336-index.html	Edgar Link	pending
0001564590-18-030336.txt	Edgar Link	pending
0001564590-18-030336-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g5lbiegnfmfb000001.jpg	Edgar Link	pending
glgjmwgug1jk000001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
srdx-10k_20180930.htm	Edgar Link	pending
srdx-20180930.xml	Edgar Link	completed
srdx-20180930.xsd	Edgar Link	pending
srdx-20180930_cal.xml	Edgar Link	unprocessable
srdx-20180930_def.xml	Edgar Link	unprocessable
srdx-20180930_lab.xml	Edgar Link	unprocessable
srdx-20180930_pre.xml	Edgar Link	unprocessable
srdx-ex1034_316.htm	Edgar Link	pending
srdx-ex21_9.htm	Edgar Link	pending
srdx-ex23_6.htm	Edgar Link	pending
srdx-ex311_7.htm	Edgar Link	pending
srdx-ex312_10.htm	Edgar Link	pending
srdx-ex321_8.htm	Edgar Link	pending
srdx-ex322_12.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SRDX
SURMODICS INC Stock $srdx

2018 Q3 Form 10-K Financial Statement

#000156459018030336 Filed on November 30, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRDX SURMODICS INC Stock $srdx

2018 Q3 Form 10-K Financial Statement

#000156459018030336 Filed on November 30, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRDX
SURMODICS INC Stock $srdx